Product Information
TIMOLOL MALEATE 0.5% EYE DROPS is a generic product labeled by Bausch & Lomb Americas Inc., priced at $1.0460 per ML under NDC 82260081305. Its NADAC has been published 125 times since May 15, 2024.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AT1.
The High Outlier badge above means this manufacturer's average price in the Timolol Maleate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/mL
Manufacturer
Bausch & Lomb Americas Inc.NDC
82260081305
Classification
Generic
Dosage Form
SOLUTION
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
TIMOLOL MALEATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA018086FDA Approved
Before 1982
TE Code
AT1
On Market Since
6/1/2020
Pharmacological Classes
Price Statistics
The NADAC for TIMOLOL MALEATE 0.5% EYE DROPS has been published 125 times since May 15, 2024, and over the history we have for it it has risen 7.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0460 per ML |
|---|---|
| All-time high | $1.1256 (Apr 16, 2025) |
| All-time low | $0.8871 (Nov 20, 2024) |
| 52-week high | $1.0969 |
| 52-week low | $1.0406 |
| Median price | $1.0799 |
| Average price | $1.0597 |
| Largest weekly change | +19.3% (Jun 19, 2024) |
| Weeks tracked | 125 |
| Tracking since | May 15, 2024 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 31% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bausch & Lomb Americas Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Timolol Maleate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TIMOLOL MALEATE 0.5% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for TIMOLOL MALEATE 0.5% EYE DROPS, manufactured by Bausch & Lomb Americas Inc., is $1.0460 per ML (NDC 82260081305), effective Sep 30, 2026.
How has the price of TIMOLOL MALEATE 0.5% EYE DROPS changed over time?
Over the history we have for it, the NADAC for TIMOLOL MALEATE 0.5% EYE DROPS has risen 7.6%. It has been tracked across 125 weekly CMS publications since May 15, 2024.
What are the highest and lowest recorded NADAC prices for TIMOLOL MALEATE 0.5% EYE DROPS?
Since May 15, 2024, the NADAC for TIMOLOL MALEATE 0.5% EYE DROPS has ranged from a low of $0.8871 (Nov 20, 2024) to a high of $1.1256 (Apr 16, 2025), with a median of $1.0799 per ML.
Are there cheaper alternatives to TIMOLOL MALEATE 0.5% EYE DROPS?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TIMOLOL MALEATE 0.5% EYE DROPS, is $0.7197 per ML — about 31% below TIMOLOL MALEATE 0.5% EYE DROPS.
Who manufactures TIMOLOL MALEATE 0.5% EYE DROPS?
TIMOLOL MALEATE 0.5% EYE DROPS (NDC 82260081305) is labeled by Bausch & Lomb Americas Inc., and CMS classifies it as a generic product.